It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cardiac sarcoidosis (CS) is the scarring of heart muscles by autoimmunity, leading to heart abnormalities and patients with sarcoidosis with cardiac involvements have poor prognoses. Due to the small number of patients, it is difficult to stratify all patients of CS by human leukocyte antigen (HLA) analysis. We focused on the structure of antigen-recognizing pockets in heterodimeric HLA-class II, in addition to DNA sequences, and extracted high-affinity combinations of antigenic epitopes from candidate autoantigen proteins and HLA. Four HLA heterodimer-haplotypes (DQA1*05:03/05:05/05:06/05:08-DQB1*03:01) were identified in 10 of 68 cases. Nine of the 10 patients had low left ventricular ejection fraction (< 50%). Fourteen amino-acid sequences constituting four HLA anchor pockets encoded by the HLA haplotypes were all common, suggesting DQA1*05:0X-DQB1*03:01 exhibit one group of heterodimeric haplotypes. The heterodimeric haplotypes recognized eight epitopes from different proteins. Assuming that autoimmune mechanisms might be activated by molecular mimicry, we searched for bacterial species having peptide sequences homologous to the eight epitopes. Within the peptide epitopes form the SLC25A4 and DSG2, high-homology sequences were found in Cutibacterium acnes and Mycobacterium tuberculosis, respectively. In this study, we detected the risk heterodimeric haplotypes of ventricular dysfunction in CS by searching for high-affinity HLA-class II and antigenic epitopes from candidate cardiac proteins.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
2 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University Graduate School of Medicine, Department of Legal Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
3 Tokyo University of Pharmacy and Life Sciences, Laboratory of Computational Genomics, School of Life Science, Hachioji, Japan (GRID:grid.410785.f) (ISNI:0000 0001 0659 6325)
4 Kanazawa University Hospital, Department of Cardiovascular Medicine, Kanazawa, Japan (GRID:grid.412002.5) (ISNI:0000 0004 0615 9100)
5 University of the Ryukyus Graduate School of Medicine, Department of Cardiovascular Medicine, Nakagami, Japan (GRID:grid.267625.2) (ISNI:0000 0001 0685 5104)
6 Nara Medical University, Department of Cardiovascular Medicine, Kashihara, Japan (GRID:grid.410814.8) (ISNI:0000 0004 0372 782X)
7 Osaka General Medical Center, Department of Cardiology, Osaka, Japan (GRID:grid.416985.7) (ISNI:0000 0004 0378 3952)
8 Kanazawa University School of Medicine, Innovative Research Center, Kanazawa, Japan (GRID:grid.9707.9) (ISNI:0000 0001 2308 3329)
9 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University Graduate School of Medicine, The 1st Department of Oral and Maxillofacial Surgery, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
10 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Kyoto University Graduate School of Medicine, Department of Medical Ethics and Medical Genetics, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
11 Osaka University Graduate School of Medicine, Department of Medical Biochemistry, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
12 Nara Prefecture Seiwa Medical Center, Department of Cardiovascular Medicine, Nara, Japan (GRID:grid.136593.b)
13 Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); National Cerebral and Cardiovascular Center, Department of Genomic Medicine, Suita, Japan (GRID:grid.410796.d) (ISNI:0000 0004 0378 8307)